13
Jun
2017
VARI-SU2C Epigenetics Dream Team launches new clinical trial to combat blood cancers
International collaboration pairs immunotherapy with an epigenetic drug to stop progression of chronic myelomonocytic leukemia and myelodysplastic syndrome into acute myeloid leukemia... Read More
2
Mar
2017
Three things to know about colorectal cancer
/
March marks Colorectal Cancer Awareness Month, a time to share information and raise awareness about these devastating diseases. Here are three key... Read More
10
Oct
2016
Combinations and collaborations in the fight against cancer: An interview with Dr. Feyruz Rassool and Dr. Stephen Baylin
/
What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be... Read More
14
Sep
2016
Stand Up To Cancer hosts another incredible telecast!
/
TagsSU2C
Last Friday, Stand Up To Cancer (SU2C) hosted its fifth live telecast, which brought together top scientists, actors and musicians in support... Read More
29
Aug
2016
Vitamin C may boost effectiveness of acute myeloid leukemia treatment
/
EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any... Read More
16
Jun
2016
Stand Up To Cancer returns for fifth live roadblock telecast Friday, September 9 Bradley Cooper to executive-produce with award-winning team at Done + Dusted
/
TagsSU2C
Note: This press release was written by Stand Up To Cancer (SU2C). Van Andel Research Institute (VARI) is home to the VARI-SU2C Epigenetics... Read More
27
Aug
2015
Researchers mimic viral infection in colon cancer stem cells, identify druggable target to potentially root out disease, end relapse
/
Note: This press release was written by Princess Margaret Cancer Centre. Dr. Peter Jones, Van Andel Research Institute’s (VARI) research director, is a... Read More
26
Feb
2015
Van Andel Research Institute appoints leading cancer scientist Dr. Stephen Baylin as professor
/
GRAND RAPIDS, Mich. (Feb. 26, 2015)—Renowned cancer scientist and epigenetics expert Stephen Baylin, M.D., has accepted an appointment at Van Andel Research Institute... Read More
20
Oct
2014
Stand Up To Cancer Epigenetics Dream Team continues with $7.5 million funding from Van Andel Research Institute
/
Grand Rapids, Michigan (October 20, 2014)— The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in... Read More